The downgrade from 'Overweight' to 'Neutral' by a major financial institution like JP Morgan, coupled with a significant reduction in the price target, is likely to negatively impact investor sentiment towards NYCB in the short term. This could lead to a decrease in stock price as the market adjusts to the new valuation and outlook provided by the analyst.